Cargando…

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection

Alcohol-related liver disease (ALD) consists of a wide spectrum of clinical manifestations and pathological features, ranging from asymptomatic patients to decompensated cirrhosis and hepatocellular carcinoma. Patients with heavy alcohol intake and advanced fibrosis often develop a subacute form of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Medina, Concepción, Melo, Luma, Martí-Aguado, David, Bataller, Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845676/ https://www.ncbi.nlm.nih.gov/pubmed/35430784 http://dx.doi.org/10.3350/cmh.2022.0017

Ejemplares similares

Trends in the management and burden of alcoholic liver disease
por: Mathurin, Philippe, et al.
Publicado: (2015)

Recent advances in alcoholic hepatitis
por: Rachakonda, Vikrant, et al.
Publicado: (2020)

Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
por: Alvarado-Tapias, Edilmar, et al.
Publicado: (2023)

Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
por: Stickel, Felix, et al.
Publicado: (2017)

Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
por: Stickel, Felix, et al.
Publicado: (2017)

Public health policies and alcohol-related liver disease
por: Ventura-Cots, Meritxell, et al.
Publicado: (2019)

The effect of endurance training on non‐alcoholic fatty liver disease in mice
por: Melo, Luma, et al.
Publicado: (2021)

Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
por: Jeon, Sookyoung, et al.
Publicado: (2023)

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
por: Arab, Juan Pablo, et al.
Publicado: (2021)

Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study
por: Marti-Aguado, David, et al.
Publicado: (2023)

Socioeconomic inequalities in the incidence of alcohol-related liver disease in the Latin American context
por: Roblero, Juan Pablo, et al.
Publicado: (2021)

Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis
por: Manchel, Alexandra, et al.
Publicado: (2022)

Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure
por: Ma, Jing, et al.
Publicado: (2022)

Identifying New Epigenetic Drivers of Liver Fibrosis
por: Argemi, Josepmaria, et al.
Publicado: (2018)

Nonspecific Erysipelothrix rhusiopathiae Bacteremia in a Patient with Subclinical Alcoholic Liver Disease
por: Kichloo, Asim Ahmed, et al.
Publicado: (2013)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease
por: Ratna, Anuradha, et al.
Publicado: (2021)

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
por: Stärkel, Peter, et al.
Publicado: (2019)

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
por: Deutsch-Link, Sasha, et al.
Publicado: (2022)

Early Liver Transplantation for Alcohol‐Associated Liver Disease: Need for Engagement and Education of All Stakeholders
por: Rice, John P., et al.
Publicado: (2019)

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
por: Karaoğlan, Beliz Bahar, et al.
Publicado: (2023)

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2021)

Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis
por: Molinari, Michele, et al.
Publicado: (2021)

Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
por: Sharma, Niketa, et al.
Publicado: (2023)

Advances in Alcoholic Liver Disease
por: Osna, Natalia, et al.
Publicado: (2012)

Gestational Age-specific Cut-off Values Are Needed for Diagnosis of Subclinical Hypothyroidism in Early Pregnancy
por: Kim, Hye Sung, et al.
Publicado: (2015)

Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA
por: Ndugga, Nambi, et al.
Publicado: (2017)

Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population
por: Hirose, Kazutoshi, et al.
Publicado: (2023)

Advances in the study of subclinical AKI biomarkers
por: Zou, Chenchen, et al.
Publicado: (2022)

Alcoholic hepatitis masquerading as tumor infiltration: Reversibility after abstinence
por: Gluskin, Adam B., et al.
Publicado: (2019)

CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
por: Duan, Yi, et al.
Publicado: (2021)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
por: Hsiao, Chia-Chi, et al.
Publicado: (2021)

Heavy alcohol drinking and subclinical echocardiographic abnormalities of structure and function
por: Iakunchykova, Olena, et al.
Publicado: (2021)

Invasive potential of biofilm-forming Staphylococci bovine subclinical mastitis isolates
por: Oliveira, Manuela, et al.
Publicado: (2011)

The use of a homeopathic preparation in the treatment of subclinical form of mastitis in cows
por: Kukeyeva, Aigerim, et al.
Publicado: (2023)

Contribution of Modern Echocardiographic Techniques in the Detection of Subclinical Heart Dysfunction in Young Adults with Non-Alcoholic Fatty Liver Disease
por: MOISE, CRISTIANA GIANINA, et al.
Publicado: (2021)

Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
por: Yari, Fatemeh Ali, et al.
Publicado: (2021)

Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
por: Wong, Mark Yu Zheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tr2qtovprb7ac8mvaia7hho6s7